| Original language | English |
|---|---|
| Pages (from-to) | 261-262 |
| Number of pages | 2 |
| Journal | Journal of Gene Medicine |
| Volume | 5 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2003 |
Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT).
Research output: Contribution to journal › Article › peer-review
50
Scopus
citations